First Citizens Bank & Trust Co. Acquires New Shares in SPDR S&P Pharmaceuticals ETF $XPH

First Citizens Bank & Trust Co. acquired a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 170,502 shares of the company’s stock, valued at approximately $11,083,000. First Citizens Bank & Trust Co. owned about 2.35% of SPDR S&P Pharmaceuticals ETF as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Bank of America Corp DE increased its holdings in shares of SPDR S&P Pharmaceuticals ETF by 128.0% in the first quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock valued at $43,918,000 after purchasing an additional 455,802 shares during the last quarter. Private Advisor Group LLC bought a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at about $3,017,000. Integrated Wealth Concepts LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth approximately $3,350,000. Avior Wealth Management LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $1,172,000. Finally, SummitTX Capital L.P. bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth approximately $843,000.

SPDR S&P Pharmaceuticals ETF Trading Down 3.0%

Shares of XPH stock opened at $62.10 on Wednesday. The stock has a market cap of $450.23 million, a P/E ratio of 14.28 and a beta of 0.61. The stock has a 50 day simple moving average of $68.53 and a 200 day simple moving average of $63.59. SPDR S&P Pharmaceuticals ETF has a 1 year low of $46.90 and a 1 year high of $74.35.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.